Physician profile
Lincoln E Tom
NPI 1629186820
$607.64
in general payments reported to CMS, 2019-2025
10 companies · $69.73 in 2025
The $69.73 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $11.80 · 2021: $83.04 · 2022: $27.15 · 2023: $177 · 2024: $111 · 2025: $69.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $373.49 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $57.25 | 2019-2021 | |
| Exact Sciences Corporation | $48.41 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Inari Medical, INC. | $27.07 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $21.41 | 2025 | |
| Boston Scientific Corporation | $20.98 | 2019 | |
| Silk Road Medical, INC. | $16.98 | 2021 | |
| Seqirus USA INC | $15.74 | 2024 | Fluad, Flucelvax |
| Nevro Corp. | $14.51 | 2021 | |
| Merck Sharp & Dohme LLC | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lincoln Tom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.